| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 06/27/2006 | US7067273 Comprises amino acid sequences which serve as substrates for a disintegrin and metalloprotease (ADAM) for use in identification of modulator for treatment of asthma |
| 06/27/2006 | US7067272 Thin membrane comprising transferrins for measuring matrix metalloproteinase 7 activity; diagnosing cancer, periodontal diseases and arteriosclerosis |
| 06/27/2006 | US7067271 screening for compounds that inhibit Amyloid-beta production by contacting a segment of a beta -secretase enzyme protein lacking a transmembrane region; amyloid precursor proteins |
| 06/27/2006 | US7067266 Invention provides nucleic acids and proteins capable of modulating leukocyte activation and platelet proliferation; concerns disorders related to dysfunction and dysregulation of leukocyte activation or platelet proliferation |
| 06/27/2006 | US7067265 Transgenic cells coding membrane protein which controls intracellular hydrogen ion concentration for identifying modulators for treatment of diabetes |
| 06/27/2006 | US7067263 High throughput screening assay systems in microscale fluidic devices |
| 06/27/2006 | US7067262 Determination binding of gabapentin to cells |
| 06/27/2006 | US7067261 Methods and compositions for treatment of central nervous system disorders |
| 06/27/2006 | US7067260 Detecting modulators of receptor binding activity; obtain sample containing receptor protein, incubate with modulator, monitor and evaluate protein binding |
| 06/27/2006 | US7067259 Multidrug resistance proteins in Drosophila and Anopheles |
| 06/27/2006 | US7067258 immunoassay for measuring the presence/titre of neutralizing antibodies in a test sample to HPV types are determined where known, type-specific, fluorescently labeled monoclonal antibodies compete with antibodies within a sample for binding to sensitive, neutralizing epitopes on specific HPV-VLP |
| 06/27/2006 | US7067256 Ribozyme mediated inactivation of the androgen receptor |
| 06/27/2006 | US7067255 Hereditary hemochromatosis gene |
| 06/27/2006 | US7067254 Detection of inflammatory response in mammals; obtain cells, culture, incubate with test compound, monitor cell response, compare to control, evaluate for inflammatory response |
| 06/27/2006 | US7067253 Method and device for identifying a polymer |
| 06/27/2006 | US7067252 Detecting preferential gene products in sample; obtain sample, generate antibodies to gene product, obtain cell, transform with vector containing preferential gene product, incubate with antibody, detect signal from bound antibody |
| 06/27/2006 | US7067251 Methods of directly selecting cells expressing inserts of interest |
| 06/27/2006 | US7067250 Detecting expression of Rna transcribed from tumor antigen protein; detection hybridization; cancer screening |
| 06/27/2006 | US7067248 Screening method for orthopoxvirus antivirals |
| 06/27/2006 | US7067246 measuring the levels of anti-tat antibodies and p24 protein in the serum of an HIV infected individual; comparing the measured levels to a mean anti-tat antibody value |
| 06/27/2006 | US7067245 selecting a host or replicator virus by by growing a population of viruses in a high selection pressure strain of bacteria where activity of interest confers a growth advantage; expanding the virus population, cycling the virus population through the process again |
| 06/27/2006 | US7067244 Rapid triglyceride assay for use in pulp pitch control |
| 06/27/2006 | US7067136 Proteins; gene expression of antigen in vivo; genetic engineering; detection of antibiotics ; drug design; plasmids |
| 06/27/2006 | US7067130 Genetic engineering; polypeptide; cancer diagnosis |
| 06/27/2006 | US7067126 Synthase enzymes having chemokine, angiogenic or angiostsatic activity, used for medical diagnosis and prognosis |
| 06/27/2006 | CA2426283C Method for direct rescue and amplification of integrated viruses from cellular dna of tissues |
| 06/27/2006 | CA2283740C Method for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the same |
| 06/27/2006 | CA2267280C Sample collection and delivery device |
| 06/27/2006 | CA2252474C Biosensor device and method |
| 06/27/2006 | CA2237224C Synthetic hpv11 virus-like particles |
| 06/24/2006 | CA2494575A1 Compositions and methods for the treatment of osteoporosis |
| 06/24/2006 | CA2491067A1 Mrna rations in urinary sediments and/or urine as a prognostic marker for prostate cancer |
| 06/22/2006 | WO2006066240A2 Methods for assessing patients with acute myeloid leukemia |
| 06/22/2006 | WO2006066224A2 Virulence targeted antibiotics |
| 06/22/2006 | WO2006066205A2 System and method for inspection of a workpiece surface using multiple scattered light collectors |
| 06/22/2006 | WO2006066203A2 Small interfering rna (sirna) molecules for modulating superoxide dismutase (sod) |
| 06/22/2006 | WO2006066158A2 Rnai modulation of mll-af4 and uses thereof |
| 06/22/2006 | WO2006066071A2 Prognosis of renal cell carcinoma |
| 06/22/2006 | WO2006066008A2 Device and methods for identifying and treating aspirin non-responsive patients |
| 06/22/2006 | WO2006065971A2 Compositions and methods for polynucleotide amplification and detection |
| 06/22/2006 | WO2006065940A2 Identification and use of prognostic and predictive markers in cancer treatment |
| 06/22/2006 | WO2006065900A1 Size self-limiting compositions and test devices for measuring analytes in biological fluids |
| 06/22/2006 | WO2006065897A2 Device for the detection of prions |
| 06/22/2006 | WO2006065758A2 Diagnostic assay for wiskott-aldrich syndrome and genetically related disorders |
| 06/22/2006 | WO2006065732A2 Compositions and methods for nucleic acid analysis of sequences with insertions or deletions |
| 06/22/2006 | WO2006065597A2 Id-tag complexes, arrays, and methods of use thereof |
| 06/22/2006 | WO2006065273A2 New human parvovirus |
| 06/22/2006 | WO2006065230A1 Method of nucleic acid signal detection |
| 06/22/2006 | WO2006065125A1 Means and methods for determining and/or influencing transportation |
| 06/22/2006 | WO2006065051A1 Method of fabricating biochip |
| 06/22/2006 | WO2006064964A1 Method of identifying gene with variable expression |
| 06/22/2006 | WO2006064914A1 Neuraminidase inhibitor |
| 06/22/2006 | WO2006064864A1 Method of assessing cancerous conditions and reagent for detecting gene product to be used in the method |
| 06/22/2006 | WO2006064861A1 Function inhibitor of adam10 or adam17 protein and method of screening the same |
| 06/22/2006 | WO2006064745A1 Method of identifying nucleotide polymorphisms |
| 06/22/2006 | WO2006064739A1 Method of treating biological sample for performing nucleic acid amplification |
| 06/22/2006 | WO2006064737A1 Method of detecting gene methylation and method of examining neoplasm by detecting methylation |
| 06/22/2006 | WO2006064686A1 Drug and method for preventing or relieving delayed nerve cell death |
| 06/22/2006 | WO2006064631A1 Method, program and system for the standardization of gene expression amount |
| 06/22/2006 | WO2006064591A1 Substrate and method of quantifying target substance |
| 06/22/2006 | WO2006064488A1 A kit for colorimetric assays of food and beverage analytes |
| 06/22/2006 | WO2006064487A1 Assay for determination of free d-galactase and/or l-arabinose |
| 06/22/2006 | WO2006064199A1 Improved method of nucleotide detection |
| 06/22/2006 | WO2006064115A1 USE OF NUCLEOTIDE SEQUENCES PREFERABLY INTERACTING WITH THE TRANSCRIPTION COMPLEX PPAR α |
| 06/22/2006 | WO2006064072A1 Peptides, nucleotide sequences and cnalinker13 cells and applications thereof |
| 06/22/2006 | WO2006063800A1 Cloning of honey bee allergen |
| 06/22/2006 | WO2006063752A1 Improved mevalonate kinase |
| 06/22/2006 | WO2006063723A2 High-throughput enzyme-linked immuno absorbent assay (ht-elisa) for identifying r rho-kinase (rok) modulator |
| 06/22/2006 | WO2006063717A2 Polymerase-independent analysis of the sequence of polynucleotides |
| 06/22/2006 | WO2006063704A2 Single nucleotide polymorphism (snp) associated to type ii diabetes |
| 06/22/2006 | WO2006063703A2 Single nucleotide polymorphism (snp) associated to type ii diabetes |
| 06/22/2006 | WO2006063587A1 Testing the activity of an enzyme using absorbance |
| 06/22/2006 | WO2006063462A1 Polynucleotides and polypeptide sequences involved in the process of bone remodeling |
| 06/22/2006 | WO2006063428A1 Lactic acid bacteria for the treatment of food |
| 06/22/2006 | WO2006063397A1 Determinants of sensitivity to chemotherapeutic agents |
| 06/22/2006 | WO2006063376A1 Method for the detection of adenoviruses |
| 06/22/2006 | WO2006048757A3 Anti-bacterial vaccine compositions |
| 06/22/2006 | WO2006047336A3 Infrared measurement for the rapid enumeration of microbial concentrations |
| 06/22/2006 | WO2006042158A3 Methods and compositions for improving recombinant protein production |
| 06/22/2006 | WO2006040047A3 Diagnostics and therapeutics for diseases associated with rho/rac-interacting citron kinase (cit) |
| 06/22/2006 | WO2006036637A3 Assay method for drugs to treat atherosclerosis, cancer and alzheimer’s disease |
| 06/22/2006 | WO2006034811A3 Use of laccases as reporter genes |
| 06/22/2006 | WO2006034417A3 Trivalent metal mediated homogeneous luminescent proximity assay |
| 06/22/2006 | WO2006034356A9 Cardiac pressure overload associated genes |
| 06/22/2006 | WO2006027702A3 Analyte detecting member with a 3d hydrogel |
| 06/22/2006 | WO2006024951A3 Method for analyzing genes of industrial yeasts |
| 06/22/2006 | WO2006018259A3 Method of screening for a carnitine transporter agonist or antagonist and its uses |
| 06/22/2006 | WO2006014958A3 Platelet activation markers as predictors of disease and of response to therapy and for monitoring therapeutic progress |
| 06/22/2006 | WO2006010610A3 Method for determining the abundance of sequences in a sample |
| 06/22/2006 | WO2006010514A3 Diagnostics and therapeutics for diseases associated with dual specificity mitogen-activated protein kinase kinase 5 (map2k5) |
| 06/22/2006 | WO2006009870A3 Compositions and methods for preventing carry-over contamination in nucleic acid amplification reactions |
| 06/22/2006 | WO2006008008A3 Diagnostics and therapeutics for diseases associated with hepatocyte nuclear factor 4, alpha (hnf4a) |
| 06/22/2006 | WO2006007450A3 Detection, evaluation and treatment for advanced prostate cancer |
| 06/22/2006 | WO2005122296A3 An electrode device, process for making an electrode device and a method of electrochemical detection using an electrode device |
| 06/22/2006 | WO2005118887A3 Human antibodies interacting with hiv gp41 |
| 06/22/2006 | WO2005118865A3 Diagnosis and treatment of drug resistant leukemia |
| 06/22/2006 | WO2005113797A3 METHODS FOR DETECTING Lp-PLA2 ACTIVITY AND INHIBITION OF Lp-PLA2 ACTIVITY |
| 06/22/2006 | WO2005111244A3 Methods for detecting a mutant nucleic acid |
| 06/22/2006 | WO2005108626A3 Mutants of staphylococcal mrs and methods of use |
| 06/22/2006 | WO2005106002A3 Polyvalent viral vectors and a system for production thereof |